Tower Research Capital LLC (TRC) - IMMUNOVANT INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$369,619
+997.1%
9,628
+442.1%
0.01%
+1100.0%
Q2 2023$33,691
+10363.0%
1,776
-91.5%
0.00%
-90.0%
Q1 2023$322
+455.2%
20,801
+540.6%
0.01%
+400.0%
Q4 2022$58
-99.9%
3,247
-72.2%
0.00%
+100.0%
Q3 2022$65,000
+195.5%
11,683
+102.8%
0.00%
Q2 2022$22,000
-61.4%
5,760
-44.8%
0.00%
-100.0%
Q1 2022$57,000
-14.9%
10,430
+31.4%
0.00%0.0%
Q4 2021$67,000
-24.7%
7,938
-22.8%
0.00%
-50.0%
Q3 2021$89,000
+107.0%
10,287
+151.7%
0.00%
+100.0%
Q2 2021$43,000
-53.3%
4,087
-28.9%
0.00%
-50.0%
Q1 2021$92,000
-18.6%
5,746
+134.5%
0.00%
-33.3%
Q4 2020$113,000
-18.7%
2,450
-37.9%
0.00%
+50.0%
Q3 2020$139,000
+434.6%
3,946
+274.0%
0.00%
+100.0%
Q2 2020$26,0001,0550.00%
Other shareholders
IMMUNOVANT INC shareholders Q4 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 3,007,000$25,620,0003.77%
Deep Track Capital, LP 4,775,000$40,683,0002.87%
Octagon Capital Advisors LP 572,862$4,881,0000.95%
Eventide Asset Management 4,950,000$42,174,0000.54%
WITTENBERG INVESTMENT MANAGEMENT, INC. 140,500$1,197,0000.44%
FRAZIER MANAGEMENT LLC 585,759$4,991,0000.38%
MANGROVE PARTNERS IM, LLC 688,000$5,862,0000.35%
BCK CAPITAL MANAGEMENT LP 54,293$463,0000.31%
EcoR1 Capital, LLC 1,140,819$9,720,0000.31%
MANGROVE PARTNERS IM, LLC 570,400$4,860,0000.29%
View complete list of IMMUNOVANT INC shareholders